Align Technology | ALGN - Operating Profit


Align Technology reported $178.05M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
3M USD 1.55B 337M Mar/2026
Align Technology USD 178.05M 46.66M Mar/2026
Becton, Dickinson and Co. USD 627M 36M Mar/2026
Bruker USD 10.2M 66.1M Mar/2026
Cardinal Health USD 861M 98M Mar/2026
Charles River Laboratories USD 119.9M 44.08M Mar/2026
Cooper Companies USD -31M 243.8M Mar/2026
CVS Health USD 4.68B 2.57B Mar/2026
Danaher USD 1.34B 158M Mar/2026
Dentsply International USD 32M 506M Mar/2026
Dexcom USD 255.3M 67.7M Mar/2026
Henry Schein USD 182M 4M Mar/2026
Idexx Laboratories USD 362.59M 46.98M Mar/2026
Insulet USD 122M 24.3M Mar/2026
Integra LifeSciences USD 11.47M 54.54M Mar/2026
IQVIA Holdings USD 565M 2.11B Mar/2026
Masimo USD 77.4M 6.5M Mar/2026
McKesson USD 1.84B 181M Mar/2026
Mettler Toledo International USD 233.93M 118M Mar/2026
Revvity USD 82.77M 63.06M Mar/2026
Solventum Corp USD 85M 20M Mar/2026
Stryker USD 1.1B 867M Mar/2026
Teleflex USD 37.03M 686K Mar/2026
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Veeva Systems USD 273.11M 27.24M Mar/2026
Waters USD 148M 122.52M Mar/2026
Zimmer Biomet Holdings USD 395.1M 92.2M Mar/2026
Zoetis USD 865M 30M Mar/2026